XML 62 R26.htm IDEA: XBRL DOCUMENT v3.3.0.814
Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)
 6 Months Ended 12 Months Ended
Sep. 30, 2015
Mar. 31, 2015
Dec. 31, 2014
Summary Of Significant Accounting Policies [Line Items]      
Health Care Organization, Patient Service Revenue $ 20,000    
Financial Liabilities Fair Value Disclosure $ 1,703,996 $ 2,586,854  
Percentage of Interest Rate for Certificates 0.15%    
Deferred Costs, Total   $ 514,000  
Warrant Liability      
Summary Of Significant Accounting Policies [Line Items]      
Expected term 5 years 6 months 6 years  
Risk free interest rate 1.37% 1.53%  
Expected volatility rate 58.10% 57.40%  
Share Price $ 5.10 $ 5.00  
Percentage For Down round financing 50.00% 50.00%  
Financial Liabilities Fair Value Disclosure $ 1,315,846 $ 2,144,496  
Conversion Feature Liability      
Summary Of Significant Accounting Policies [Line Items]      
Expected term 3 years 6 months 4 years  
Risk free interest rate 1.00% 1.10%  
Expected volatility rate 45.50% 47.60%  
Share Price $ 5.10 $ 5.00  
Percentage For Down round financing 100.00% 100.00%  
Debt Instrument, Interest Rate, Stated Percentage 8.00% 8.00%  
Debt Instrument, Convertible, Conversion Price $ 10.00 $ 10.00  
Financial Liabilities Fair Value Disclosure $ 388,150 $ 442,358  
Maximum      
Summary Of Significant Accounting Policies [Line Items]      
Management agreement, initial term 20 years    
Minimum      
Summary Of Significant Accounting Policies [Line Items]      
Management agreement, initial term 10 years    
ApolloMed ACO      
Summary Of Significant Accounting Policies [Line Items]      
Benchmark Expenditure     $ 3,900,000
Percentage of Quality Score     90.40%
ApolloMed Palliative      
Summary Of Significant Accounting Policies [Line Items]      
Business Combination, Consideration Transferred, Total $ 586,111